- Home
- FHN vs PEN Comparison
FHN vs PEN Comparison
Compare FHN & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FHN
- PEN
- Stock Information
- Founded
- FHN 1864
- PEN 2004
- Country
- FHN United States
- PEN United States
- Employees
- FHN N/A
- PEN N/A
- Industry
- FHN Major Banks
- PEN Medical/Dental Instruments
- Sector
- FHN Finance
- PEN Health Care
- Exchange
- FHN Nasdaq
- PEN Nasdaq
- Market Cap
- FHN 11.0B
- PEN 9.7B
- IPO Year
- FHN N/A
- PEN 2015
- Fundamental
- Price
- FHN $21.69
- PEN $274.65
- Analyst Decision
- FHN Buy
- PEN Strong Buy
- Analyst Count
- FHN 20
- PEN 16
- Target Price
- FHN $24.10
- PEN $307.19
- AVG Volume (30 Days)
- FHN 14.9M
- PEN 447.8K
- Earning Date
- FHN 10-15-2025
- PEN 11-05-2025
- Dividend Yield
- FHN 2.73%
- PEN N/A
- EPS Growth
- FHN 19.36
- PEN 367.34
- EPS
- FHN 1.65
- PEN 4.14
- Revenue
- FHN $3,184,000,000.00
- PEN $1,333,798,000.00
- Revenue This Year
- FHN $12.70
- PEN $15.52
- Revenue Next Year
- FHN $2.54
- PEN $14.20
- P/E Ratio
- FHN $13.28
- PEN $65.00
- Revenue Growth
- FHN 3.75
- PEN 14.61
- 52 Week Low
- FHN $15.19
- PEN $221.26
- 52 Week High
- FHN $23.70
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- FHN 51.78
- PEN 66.01
- Support Level
- FHN $20.99
- PEN $225.52
- Resistance Level
- FHN $22.04
- PEN $272.00
- Average True Range (ATR)
- FHN 0.47
- PEN 9.22
- MACD
- FHN 0.14
- PEN 4.57
- Stochastic Oscillator
- FHN 74.67
- PEN 96.73
About FHN First Horizon Corporation
First Horizon Corp is the parent company of First Tennessee Bank, a prominent regional bank with about 200 branches around Tennessee. The company's reportable segments are: Commercial, Consumer & Wealth, Wholesale, and Corporate. The majority of its revenue is generated from Commercial, Consumer & Wealth. The Commercial, Consumer & Wealth segment offers financial products and services, including traditional lending and deposit taking, to commercial and consumer clients in the southern USA and other selected markets.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.